title: Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
abstract: X-ray crystallography studies, as well as live-cell fluorescent imaging, have recently challenged the traditional view of protein kinase CK2. Unbalanced expression of catalytic and regulatory CK2 subunits has been observed in a variety of tissues and tumours. Thus the potential intersubunit flexibility suggested by these studies raises the likely prospect that the CK2 holoenzyme complex is subject to disassembly and reassembly. In the present paper, we show evidence for the reversible multimeric organization of the CK2 holoenzyme complex in vitro. We used a combination of site-directed mutagenesis, binding experiments and functional assays to show that, both in vitro and in vivo, only a small set of primary hydrophobic residues of CK2beta which contacts at the centre of the CK2alpha/CK2beta interface dominates affinity. The results indicate that a double mutation in CK2beta of amino acids Tyr188 and Phe190, which are complementary and fill up a hydrophobic pocket of CK2alpha, is the most disruptive to CK2alpha binding both in vitro and in living cells. Further characterization of hotspots in a cluster of hydrophobic amino acids centred around Tyr188-Phe190 led us to the structure-based design of small-peptide inhibitors. One conformationally constrained 11-mer peptide (Pc) represents a unique CK2beta-based small molecule that was particularly efficient (i) to antagonize the interaction between the CK2 subunits, (ii) to inhibit the assembly of the CK2 holoenzyme complex, and (iii) to strongly affect its substrate preference.
authors: Inserm, U873, Grenoble, F-38054, France.
authors: Béatrice
authors: B
authors: Laudet
authors: Caroline
authors: C
authors: Barette
authors: Vincent
authors: V
authors: Dulery
authors: Olivier
authors: O
authors: Renaudet
authors: Pascal
authors: P
authors: Dumy
authors: Alexandra
authors: A
authors: Metz
authors: Renaud
authors: R
authors: Prudent
authors: Alexandre
authors: A
authors: Deshiere
authors: Otto
authors: O
authors: Dideberg
authors: Odile
authors: O
authors: Filhol
authors: Claude
authors: C
authors: Cochet
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D047390:Casein Kinase II / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D002384:Catalysis; D018360:Crystallography, X-Ray; D017931:DNA Primers; D006367:HeLa Cells; D006801:Humans; D008024:Ligands; D016297:Mutagenesis, Site-Directed; D010455:Peptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance
chemical_list: D017931:DNA Primers; D008024:Ligands; D010455:Peptides; D047428:Protein Kinase Inhibitors; D011994:Recombinant Proteins; D047390:Casein Kinase II
references: Nat Biotechnol. 2003 May;21(5):539-45
references: 12692560
references: Oncogene. 2006 Nov 30;25(56):7343-53
references: 16751801
references: J Cell Sci. 2002 Oct 15;115(Pt 20):3873-8
references: 12244125
references: Science. 1997 May 9;276(5314):952-5
references: 9139659
references: Eur J Biochem. 1991 May 23;198(1):25-30
references: 2040287
references: Ann N Y Acad Sci. 2002 Nov;973:272-7
references: 12485876
references: Nature. 1998 Sep 17;395(6699):297-300
references: 9751060
references: FASEB J. 1995 Mar;9(5):313-23
references: 7896000
references: Bioessays. 1995 Jun;17(6):471-80
references: 7575488
references: Mol Cell Biol. 2003 Feb;23(3):975-87
references: 12529402
references: EMBO Rep. 2004 Apr;5(4):351-5
references: 15060571
references: Biochem J. 2003 Jan 1;369(Pt 1):1-15
references: 12396231
references: DNA Repair (Amst). 2002 Mar 28;1(3):225-35
references: 12509254
references: Oncogene. 2003 Jan 16;22(2):220-32
references: 12527891
references: EMBO J. 1999 Jun 1;18(11):2930-40
references: 10357806
references: Biochemistry. 1991 Nov 19;30(46):11133-40
references: 1932033
references: J Comput Chem. 2004 Oct;25(13):1605-12
references: 15264254
references: J Cell Biochem Suppl. 1998;30-31:129-36
references: 9893264
references: FEBS Lett. 1999 Dec 3;462(3):353-7
references: 10622724
references: Mol Cell Biochem. 2005 Jun;274(1-2):15-22
references: 16335524
references: Org Lett. 2003 Feb 6;5(3):243-6
references: 12556162
references: Int J Biol Sci. 2005;1(2):67-79
references: 15951851
references: Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81
references: 12800163
references: ChemMedChem. 2006 Apr;1(4):400-11
references: 16892375
references: Nat Rev Mol Cell Biol. 2006 Jun;7(6):449-56
references: 16625152
references: Biochem J. 2001 Aug 15;358(Pt 1):87-94
references: 11485555
references: J Biol Chem. 1996 Jul 26;271(30):17798-803
references: 8663446
references: J Biol Chem. 1997 Dec 19;272(51):31998-2005
references: 9405392
references: EMBO J. 2001 Oct 1;20(19):5320-31
references: 11574463
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2184-95
references: 15572771
references: Mol Cell Biol. 2006 Apr;26(8):3008-17
references: 16581776
references: Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
references: 15299374
references: Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11273-8
references: 13679575
references: Eur J Biochem. 1986 Jul 1;158(1):99-106
references: 3089780
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references: 15572765
references: Biochemistry. 1997 Jun 10;36(23):7192-8
references: 9188720
references: Mol Cell Biochem. 2005 Jun;274(1-2):23-9
references: 16335525
references: J Biol Chem. 1997 Jun 27;272(26):16343-50
references: 9195940
references: Mol Cell Biochem. 1999 Jan;191(1-2):43-50
references: 10094391
references: J Mol Biol. 2003 Jul 25;330(5):925-34
references: 12860116
references: J Biol Chem. 1990 Nov 25;265(33):20609-15
references: 2243106